Masamune Mitsumoto

Suggest Changes
Learn More
To establish a more suitable model for reflecting biological aggressiveness in clinically recurrent cancers after chemotherapy, we made the in-vitro-established cisplatin-resistant cell lines, by(More)
  • 1